UPDATE: Protagonist Therapeutics (PTGX) PT Lowered to $51 at JPMorgan
Tweet Send to a Friend
(Updated - March 1, 2022 11:43 AM EST)
JPMorgan analyst Anupam Rama lowered the price target on Protagonist Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Anupam Rama lowered the price target on Protagonist Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
